Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.AuthorsLück, Hans-Joachim; Lübbe, Kristina; Reinisch, Mattea; Maass, Nicolai; Feisel-Schwickardi, Gabriele; Tomé, Oliver; Janni, Wolfgang; Aydogdu, Mustafa; Neunhöffer, Tanja; Ober, Angelika; Aktas, Bahriye; Park-Simon, Tjoung-Won; Schumacher, Claudia; Höffkes, Heinz-Gert; Illmer, Thomas; Wagner, Harald; Mehta, Keyur; Minckwitz, Gunter; Nekljudova, Valentina; Loibl, SibyllePublicationBreast Cancer Research & Treatment, 2015, Vol 149, Issue 1, p141ISSN0167-6806Publication typeArticleDOI10.1007/s10549-014-3217-y